Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Herbal Formula Corresponding to Syndrome in Treating Post Percutaneous Coronary Intervention (PCI) Patients With Coronary Heart Disease (CHD)

This study has been completed.
Sponsor:
Collaborator:
Beijing Anzhen Hospital
Information provided by:
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
ClinicalTrials.gov Identifier:
NCT00817024
First received: January 4, 2009
Last updated: May 31, 2012
Last verified: January 2009